ASLAN Pharmaceuticals (NASDAQ:ASLN) Monday filed a prospectus related to the proposed resale of about 5M ADS, representing about 125M shares, by selling stockholders. This prospectus is not an offer ...
Source LinkASLAN Pharmaceuticals (NASDAQ:ASLN) Monday filed a prospectus related to the proposed resale of about 5M ADS, representing about 125M shares, by selling stockholders. This prospectus is not an offer ...
Source Link
Comments